Smith & Nephew (NYSE:SNN) Cut to Hold at Berenberg Bank

Berenberg Bank lowered shares of Smith & Nephew (NYSE:SNN) from a buy rating to a hold rating in a research note released on Wednesday, Marketbeat Ratings reports.

A number of other brokerages have also weighed in on SNN. StockNews.com upgraded shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Monday, August 5th. Deutsche Bank Aktiengesellschaft cut Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Three analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy”.

Smith & Nephew Trading Down 1.7 %

Shares of SNN stock opened at $24.29 on Wednesday. Smith & Nephew has a fifty-two week low of $23.65 and a fifty-two week high of $31.72. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. The stock’s fifty day moving average price is $29.37 and its two-hundred day moving average price is $27.82.

Institutional Trading of Smith & Nephew

Institutional investors and hedge funds have recently bought and sold shares of the stock. Mather Group LLC. grew its position in shares of Smith & Nephew by 9,735.3% in the 2nd quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider’s stock valued at $42,000 after buying an additional 1,655 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in Smith & Nephew by 1,894.3% in the second quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider’s stock valued at $43,000 after acquiring an additional 1,648 shares during the last quarter. GAMMA Investing LLC increased its position in Smith & Nephew by 160.0% during the 3rd quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock valued at $70,000 after purchasing an additional 1,389 shares during the period. EverSource Wealth Advisors LLC raised its holdings in Smith & Nephew by 92.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider’s stock worth $61,000 after purchasing an additional 1,179 shares during the last quarter. Finally, Headlands Technologies LLC lifted its position in shares of Smith & Nephew by 225.0% in the 1st quarter. Headlands Technologies LLC now owns 3,851 shares of the medical equipment provider’s stock worth $98,000 after purchasing an additional 2,666 shares during the period. 25.64% of the stock is currently owned by institutional investors and hedge funds.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.